en · de · es
cardarine-notes.peptides1004.com › Topic › Identity And Pharmacological Mechanism — Field Notes

Identity And Pharmacological Mechanism — Field Notes

By Editorial Desk · published 2026-04-11 · last reviewed 2026-04-25 · Topic

Everything below concerns Laboratory compound. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.

Last reviewed on 2026-04-25. Where a claim depends on a specific study, the study is described rather than over-claimed.

Identity and Pharmacological Mechanism

The compound is typically described as a laboratory compound rather than a therapeutic product. Published reports have explored its role in lipid disorders, insulin sensitivity, and exercise metabolism, yet no major drug regulator has approved it for medical use. Commercial samples sold under the cardarine name may vary in purity and identity. Analytical confirmation is therefore necessary when the material is discussed in scientific or regulatory contexts. Its classification as a prohibited substance in sport further shapes how it is studied and reported.

Cardarine is a common name for GW501516, a synthetic compound studied for its effects on lipid and glucose metabolism. It functions as an agonist at peroxisome proliferator-activated receptor delta, or PPARδ, a nuclear receptor that influences gene expression. The molecule is not a steroid, nor is it a selective androgen receptor modulator. It is also known in research and sports literature as GW-501516 and endurobol. Early laboratory work examined its metabolic activity in cell cultures and animal models.

Background and Regulatory Status

Sporting authorities added GW501516 to prohibited lists after it appeared in athlete samples and online markets. The World Anti-Doping Agency classifies it as a hormone and metabolic modulator, and its use can lead to an anti-doping rule violation. Some early laboratory work suggested effects on fatty acid oxidation and endurance-related metabolism in animals, but those findings do not establish safe or effective use in people. Reports of adverse events in humans are scarce and often anecdotal, which complicates risk assessment.

Legal status varies by country. In some places, cardarine is controlled under medicines or psychoactive substances laws; in others, it may be sold with minimal oversight as a research chemical. Customs agencies have intercepted shipments, and several national health agencies have issued warnings about products marketed for bodybuilding or performance enhancement. The lack of a standardized pharmaceutical supply means identity, purity, and contamination levels can differ widely between samples. These factors make cardarine a regulatory and public health concern rather than a conventional prescription drug.

Cardarine at a glance

PropertyValueNotes
Chemical classSynthetic PPARδ agonistNot a steroid or a selective androgen receptor modulator.
Common synonymsCardarine, GW501516, GW-501516, endurobolNames vary by supplier and literature source.
AppearanceWhite to off-white powderConsistent with many small-molecule research chemicals.
SolubilityLow in water; soluble in DMSO and ethanolOften prepared in organic solvent for laboratory work.
Primary targetPPARδ (NR1C2)Nuclear receptor involved in lipid and energy metabolism.

Regulatory Status and Detection Context

Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.

Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.

Related pages on this site

Background and Regulatory History

Cardarine is a common name for the investigational chemical GW501516, also written GW-1516. It was developed as a peroxisome proliferator-activated receptor delta agonist for metabolic conditions such as dyslipidemia. Early research focused on lipid handling and energy use in skeletal muscle and other tissues. The compound was never approved as a medicine. In public discussion, it is often grouped with performance-enhancing substances, although its receptor target differs from that of anabolic steroids or selective androgen receptor modulators. Regulatory and health authorities have issued warnings about its use.

GW501516 acts on PPARδ, a nuclear receptor that helps regulate fatty acid oxidation and energy homeostasis. In animal studies, activation of this receptor was associated with increased endurance and changes in lipid metabolism. Human trials examined effects on blood lipids and other metabolic markers, but the compound did not advance to approval. Rodent studies later reported tumors in multiple tissues at doses used in those experiments. Whether those findings translate to human risk remains uncertain, and the clinical relevance of the animal data is still debated.

Regulatory bodies treat GW501516 as a prohibited substance in competitive sport. The World Anti-Doping Agency added it to the prohibited list, and it falls under classes covering metabolic modulators and hormone-related agents. It is not approved by drug regulators for human use, and it is not a lawful dietary supplement. Products sold under the cardarine name may contain unlisted ingredients or different compounds. Because no approved product exists, quality and identity are not guaranteed by pharmaceutical manufacturing standards.

Reference notes

By the mid-1900s, lichenologists were already exploiting chemical traits for classification—decades before such methods reached vascular plant taxonomy. Because many lichens synthesize distinctive secondary metabolites (specialized compounds including lichen products unique to these organisms), workers devised simple spot tests in which reagents applied to the thallus yield diagnostic colour changes. The technique dates to the 1860s, but by 1951, the tests were routine. Elke Mackenzie listed K (potassium hydroxide solution), C (sodium hypochlorite), and Pd (p-phenylenediamine) as key diagnostic reagents because species often differ in their colour reactions. For example, a yellow K reaction usually signals the presence of the common metabolite atranorin, whereas a deep-red Pd reaction suggests certain depsidones. The chemical toolbox expanded sharply with the adoption of thin-layer chromatography (TLC) in the late 1960s. Chicita F. Culberson's Chemical and Botanical Guide to Lichen Products (1969) laid out a reproducible protocol for separating trace compounds from minute thallus chips, making TLC profiles a standard component of species descriptions. David Hawksworth's 1976 synthesis went a step further by integrating metabolite patterns into family‑ and order‑level frameworks, demonstrating that chemistry could diagnose natural groups and foreshadowing the molecular phylogenies that would follow. Chemical tests revealed cryptic diversity beneath outwardly uniform lichens.

The C-terminal domain of ADP-ribose diphosphatase contains the Nudix sequence, a highly conserved amino acid sequence that is found in over 450 putative proteins in about 90 different species. A part of this sequence known as the Nudix fold is the catalytic part of the sequence. It is a structurally conserved loop-helix-loop motif that creates a scaffold for metal binding and pyrophosphatase chemistry in the enzyme. ADP-ribose hydrolases in general act as protective agents against excessive intracellular accumulation of ADP-ribose, as high intracellular levels of ADP-ribose can be damaging to the cell. ADP-ribose diphosphatase, in particular, hydrolyzes ADP-ribose into AMP and D-ribose 5-phosphate, both of which are intermediates of central metabolic pathways and therefore are easily reused. Other common names for ADP-ribose diphosphatase include ADP-ribose pyrophosphatase and ADPRase. ADP-ribose is commonly referred to as ADPR.

During barcode sequencing, high molecular weight DNA samples that contain the targeted DNA sequence, ranging from fifty to several hundred kilobases in size, are combined with gel beads containing unique barcodes, enzymes, and sequencing reagents. Microfluidic device can partition input DNA molecules into individual nanoliter-sized droplets of water-in-oil emulsion, called GEMs. Each GEM contains gel beads coated with the same barcode and primers, and a small amount of DNA. The primers are complementary to specific regions of the DNA molecule, allowing for amplification of the DNA in the droplets through PCR. The barcodes enable the identification and grouping of sequencing reads that originate from the same long fragment, which is crucial for downstream analysis.

Direct-to-consumer blood testing (DTC blood testing), also known as direct access testing (DAT), is a form of laboratory testing that allows consumers to order blood tests directly from a clinical laboratory without requiring a prescription or referral from a physician. This market has grown significantly in recent years, driven by consumer interest in personalized health management, advances in laboratory technology, and regulatory changes that have expanded access in many jurisdictions. These services typically offer comprehensive metabolic panels, lipid profiles, hormone testing, nutritional markers, and increasingly sophisticated biomarker assessments that were traditionally only available through healthcare providers. Over the last decade, a paradigm shift has taken place with consumers seeking greater involvement in decisions affecting their healthcare and with policies that enable this involvement.

Sources: en.wikipedia.org

Reference notes

Taurine given to a range of animal species is found to boost health and extend lifespan by up to 12%. 12 June – A time-use study provides the first comprehensive bird's-eye view of what humans currently spend their time on. The "global human day" framework enables better understanding, across fields of research, of the global human system in contexts such as technological change, civilization sustainability, global challenges or goals, societal changes, and economic time allocation. It identifies some factors of variations and activities "for which there is significant potential for change". 14 June Teams of researchers report creations of synthetic human model embryos from stem cells, without the need for sperm or egg cells (see also 1 August 2022), challenging legal, ethical, and biological concepts. Scientists report evidence that the planet Earth may have formed in just three million years, much faster than the 100 million years thought earlier. Astronomers report that the presence of phosphates on Enceladus, a moon of the planet Saturn, has been detected, completing the discovery of all the basic chemical ingredients for life on the moon. IBM computer scientists report that a quantum computer produced better results for a physics problem than a conventional supercomputer. A machine learning model is trained to recognise the key features of chemicals with senolytic activity. It finds three chemicals – ginkgetin, periplocin and oleandrin – able to remove senescent cells without damaging healthy cells.

The Ghana Prisons Service and the sub-division Borstal Institute for Juveniles administers incarceration. The new sustainable development goals adopted by the United Nations call for the international community to come together to promote the rule of law; support equal access to justice for all; reduce corruption; and develop effective, accountable, and transparent institutions at all levels. Ghana is used as a key narcotics industry transshipment point by traffickers, usually from South America and some from other African nations. In 2013, the UN chief of the Office on Drugs and Crime stated that "West Africa is completely weak in terms of border control and the big drug cartels from Colombia and Latin America have chosen Africa as a way to reach Europe." The social context within which narcotic trafficking, storage, transportation, and repacking systems exist in Ghana and the state's location along the Gulf of Guinea makes Ghana a more attractive country for the narcotics business. The Narcotics Control Board has impounded container ships at the Sekondi Naval Base in the Takoradi Harbour. These ships were carrying thousands of kilograms of cocaine, with a street value running into billions of Ghana cedis. Drug seizures saw a decline in 2011. Drug cartels are using new methods in narcotics production and narcotics exportation, to avoid Ghanaian security agencies. Underdeveloped institutions, porous open borders, and the existence of established smuggling organisations contribute to Ghana's position in the narcotics industry.

Myiasis ( my-EYE-ə-səss), also known as flystrike or fly strike, is the parasitic infestation of the body of a live animal by fly larvae (maggots) that grow inside the host while feeding on its tissue. Although flies are most commonly attracted to open wounds and urine- or feces-soaked fur, some species (including the most common myiatic flies—the botfly, blowfly, and screwfly) can create an infestation even on unbroken skin. Non-myiatic flies (such as the common housefly) can be responsible for accidental myiasis. Because some animals (particularly non-native domestic animals) cannot react as effectively as humans to the causes and effects of myiasis, such infestations present a severe and continuing problem for livestock industries worldwide, causing severe economic losses where they are not mitigated by human action. Although typically a far greater issue for animals, myiasis is also a relatively frequent disease for humans in rural tropical regions where myiatic flies thrive, and often may require medical attention to surgically remove the parasites. Myiasis varies widely in the forms it takes and its effects on those affected. Such variations depend largely on the fly species and where the larvae are located. Some flies lay eggs in open wounds, other larvae may invade unbroken skin or enter the body through the nose or ears, and still others may be swallowed if the eggs are deposited on the lips or food. There can also be accidental myiasis that Eristalis tenax can cause in humans via water containing the larvae or in contaminated uncooked food.

Sources: en.wikipedia.org

Frequently asked questions

What is cardarine?

Cardarine is a common name for GW501516, a synthetic PPARδ agonist. It is not a steroid or a selective androgen receptor modulator. It was developed and studied as a research compound for metabolic pathways.

How does cardarine interact with the body?

It binds to and activates PPARδ, a nuclear receptor that regulates genes related to fatty acid oxidation and energy use. This activation alters transcription in tissues such as skeletal muscle and liver. The full range of downstream effects in humans is not fully established.

Is cardarine found naturally?

No, cardarine is not known to occur naturally in plants, animals, or humans. It is a synthetic molecule produced for laboratory research. Products labeled as cardarine should therefore be treated as manufactured chemicals with variable purity.

Is cardarine approved for human use?

No. Major drug regulators have not approved GW501516 for treating any medical condition. Products sold as cardarine are typically unapproved research chemicals or supplements, so their contents and safety are not assured.

Network